生物资讯市场规模、份额和成长分析：按产品和服务、按应用、按来源、按行业、按地区 - 行业预测，2024-2031 年

2022年生物资讯市场价值将达到132亿美元，从2023年的153.5亿美元成长到2031年的456亿美元，预测期内（2024-2031年）复合年增长率为16.3%。

市场成长主要是由不断增长的研发需求以及政府的支援措施所推动的。生物资讯软体的进步，包括 RasMol、AUTODOCK 和 BALL 等工具，也促进了这项扩展。这些复杂的工具可以在生物标记发现计画中进行准确有效的分析，对于药物开发过程中的早期毒性检测至关重要。生物资讯学涉及利用电脑技术来管理和分析生物资料，在这一领域发挥重要作用。它涵盖生物资料的储存、评估和传播，有助于了解基因和蛋白质功能、建立进化关係并预测蛋白质结构。这些进步将透过满足对资料储存和分析日益增长的需求（尤其是蛋白质组学和基因组学）来推动市场成长。例如，我们的分析表明，DNA序列测定技术现在可以在大约八小时内对人类基因组进行定序，展示了该领域的快速进展。这项进步正在推动基因组学和生物资讯学领域的需求，特别是与老化、癌症和遗传疾病预防相关的研究。这些生物资讯学应用程式有助于管理大量资料，进一步推动市场扩张。然而，生物资讯学软体和服务的高成本以及缺乏熟练专业人员等挑战可能会限制未来的市场成长。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价格分析
• 价值链分析
• 案例研究分析
• 市场生态系统
• 客户和购买标准分析
• 监管环境
• PESTEL分析
• 创新矩阵
• 重点投资分析
• 关键成功因素
• 市场魅力指数
• 竞争程度

生物资讯市场：依产品/服务分类

• 市场概况
• 知识管理工具
  • 通用知识管理工具
  • 专业知识管理工具
• 生物资讯平台
  • 资料分析平台
  • 结构/功能分析平台
  • 其他的
• 生物资讯服务
  • 定序服务
  • 资料分析服务
  • 药物发现服务
  • 差异基因表现分析服务
  • 资料库/管理服务
  • 其他的

生物资讯市场：依应用分类

• 市场概况
• 基因组学
• 化学资讯学/药物设计
• 蛋白质体学
• 转录组学
• 代谢体学
• 其他的

生物资讯市场：按部门

• 市场概况
• 医学生物技术
  • 药物发现/开发
  • 临床诊断/个人化医疗
  • 生殖健康
• 动物生物技术
• 植物生物技术
• 环境生物技术
• 法医学生物技术
• 其他的

生物资讯市场：依来源分类

• 市场概况
• 微生物
• 植物
• 动物

生物资讯市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 英国
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Illumina Inc.（US）
• Thermo Fisher Scientific Inc.（US）
• Qiagen NV（Netherlands）
• Agilent Technologies Inc.（US）
• BGI Group（China）
• PerkinElmer Inc.（US）
• Eurofins Scientific SE（Europe）
• Waters Corporation（US）
• DNAnexus Inc.（US）
• Sophia Genetics SA（Switzerland）
• Partek Incorporated（US）
• Gene Codes Corporation（US）
• Dassault Systemes SE（France）
• Biomax Informatics AG（Germany）
• Bruker Corporation（US）
• GenoLogics Life Sciences Software Inc.（US）
• Nonlinear Dynamics Ltd.（Waters Corporation）（UK）
• Genedata AG（Switzerland）
• Knome Inc.（US）
• Macrogen Inc.（South Korea）

Bioinformatics Market size was valued at USD 13.2 billion in 2022 and is poised to grow from USD 15.35 billion in 2023 to USD 45.6 billion by 2031, growing at a CAGR of 16.3% in the forecast period (2024-2031).

The growth of the market is being significantly driven by increased demand for research and development, coupled with supportive government initiatives. Advances in bioinformatics software, including tools like RasMol, AUTODOCK, and BALL, are also contributing to this expansion. These sophisticated tools enable precise and effective analysis in biomarker discovery programs, which are crucial for detecting toxicity early in drug development processes. Bioinformatics, which involves the use of computer technology to manage and analyze biological data, plays a key role in this sector. It encompasses the storage, evaluation, and dissemination of biological data, aiding in understanding gene and protein functions, establishing evolutionary relationships, and predicting protein structures. Such advancements fuel market growth by addressing the rising need for data storage and analysis, particularly in proteomics and genomics. For instance, based on our analysis, DNA sequencing technology could now sequence a human genome in approximately eight hours, showcasing rapid advancements in the field. This progress is driving demand in the genomics and bioinformatics sectors, especially for research related to aging, cancer, and genetic disease prevention. These bioinformatics applications help manage vast amounts of data, further supporting market expansion. However, challenges such as the high cost of bioinformatics software and services, along with a limited pool of skilled professionals, may pose constraints on market growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioinformatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioinformatics Market Segmental Analysis

The global bioinformatics market is segmented based on products and services, application, sector, and region. Based on products and services, the market is segmented into knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), bioinformatics platforms (data analysis platforms, structural & functional analysis platforms, other), and bioinformatics services (sequencing services, data analysis services, drug discovery services, differential gene expression analysis services, database and management services, other). Based on application, the market is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, and others. Based on sector, the market is segmented into medical biotechnology (drug discovery & development, clinical diagnostics & personalized medicine, reproductive health), animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and other. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Bioinformatics Market

The bioinformatics market has experienced significant growth driven by the increasing demand for computational epigenetics, meta-analysis of microarray data, differentially expressed genes, gene networks, and gene-associating studies, among other factors. These advancements highlight the need for sophisticated analysis tools and systems biology requirements, further propelling the market forward.However, challenges such as the absence of standardized protocols and common data formats for integration, coupled with the complexity of data and the shortage of user-friendly tools, are expected to hinder market expansion during the forecast period. These issues may slow progress by complicating data management and analysis processes.

Restraints in the Global Bioinformatics Market

The advent of advanced NGS technologies has heightened the need for fast, precise, and easy-to-use bioinformatics tools. Most experimental researchers lack specialized bioinformatics training, making user-friendly tools essential for effective use of bioinformatics platforms. Many current bioinformatics tools require advanced computing skills and suffer from inadequate user interfaces, which complicates their use for researchers without technical expertise. As a result, the development of more accessible and intuitive bioinformatics solutions is crucial to meet the growing demand for straightforward data analysis in the research community.

Market Trends of the Global Bioinformatics Market

Advancements in systems biology and pharmacogenomics have significantly propelled the shift from traditional, disease-focused medicine to a more integrative, system-based approach centered around individual patient needs. For instance, the launch of the Atlantic Cancer Consortium (ACC) in Canada, backed by over USD 3.6 million in provincial and national funding, underscores this transition. The ACC, composed of Canadian researchers, aims to develop precision medicine for cancer, highlighting the increased collaboration among medical institutions, governments, and researchers to expedite the creation of effective treatments. In addition, partnerships such as that between Summit Biolabs Inc. and the Colorado Center for Personalized Medicine (CCPM) demonstrate the growing emphasis on personalized medicine. This collaboration focuses on research and commercialization of saliva-based liquid-biopsy tests for early cancer detection and diagnosing viral infections like COVID-19. The expansion of companion diagnostics to support personalized medicine in non-oncological cases is also driving market growth. The rising incidence of cancer, in particular, fuels demand for tailored cancer therapeutics and diagnostics, further advancing the field of personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Case Study Analysis
• Ecosystem of the Market
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• PESTEL Analysis
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Bioinformatics Market by Product & Service

• Market Overview
• Knowledge Management Tools
  • Generalized Knowledge Management Tools
  • Specialized Knowledge Management Tools
• Bioinformatics Platforms
  • Data Analysis Platforms
  • Structural & Functional Analysis Platforms
  • Other
• Bioinformatics Services
  • Sequencing Services
  • Data Analysis Services
  • Drug Discovery Services
  • Differential Gene Expression Analysis Services
  • Database and Management Services
  • Other

Bioinformatics Market by Application

• Market Overview
• Genomics
• Chemoinformatics & Drug Design
• Proteomics
• Transcriptomics
• Metabolomics
• Other

Bioinformatics Market by Sector

• Market Overview
• Medical Biotechnology
  • Drug Discovery & Development
  • Clinical Diagnostics & Personalized Medicine
  • Reproductive Health
• Animal Biotechnology
• Plant Biotechnology
• Environmental Biotechnology
• Forensic Biotechnology
• Other

Bioinformatics Market by Source

• Market Overview
• Microorganisms
• Plants
• Animals

Bioinformatics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • Italy
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Europe)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNAnexus Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sophia Genetics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Partek Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene Codes Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomax Informatics AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenoLogics Life Sciences Software Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nonlinear Dynamics Ltd. (Waters Corporation) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Knome Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments